SEC Form 4 · accession 0001209191-18-055803

KYNTRA BIO, INC. · KYNB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Thomas B Neff

Officer — Chief Executive Officer · Director

Period of report

Oct 18, 2018

Accepted (ET)

Oct 19, 2018 · 8:37 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000921299

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Oct 18, 2018	M	10,319	$3.60	A	2,710,412	D
Common Stock^F2	Oct 18, 2018	S	13,136	$54.23	D	2,697,276	D
Common Stock^F3	Oct 18, 2018	S	5,364	$55.13	D	2,691,912	D
Common Stock	Oct 18, 2018	S	400	$55.90	D	2,691,512	D
Common Stock^F4	Oct 18, 2018	S	718	$54.36	D	94,076	I	By Family Partnership
Common Stock^F5	Oct 18, 2018	S	200	$55.29	D	93,876	I	By Family Partnership
Common Stock	Oct 19, 2018	M	10,319	$3.60	A	2,701,831	D
Common Stock^F6	Oct 19, 2018	S	6,100	$52.96	D	2,695,731	D
Common Stock^F7	Oct 19, 2018	S	6,300	$53.74	D	2,689,431	D
Common Stock^F8	Oct 19, 2018	S	4,700	$54.78	D	2,684,731	D
Common Stock^F9	Oct 19, 2018	S	1,800	$55.57	D	2,682,931	D
Common Stock^F10	Oct 19, 2018	S	618	$53.20	D	93,258	I	By Family Partnership
Common Stock^F11	Oct 19, 2018	S	300	$54.69	D	92,958	I	By Family Partnership
Common Stock	holding	—	—		—	19,500	I	By Spouse
Common Stock^F12	holding	—	—		—	60,946	I	See footnote

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F13	$3.60	Oct 18, 2018	M	10,319	D	—	Mar 11, 2019	Common Stock	10,319	175,423	D
Stock Option (Right to Buy)^F13	$3.60	Oct 19, 2018	M	10,319	D	—	Mar 11, 2019	Common Stock	10,319	165,104	D

Explanation of responses

F1Shares sold pursuant to a 10b5-1 plan.
F10The shares were sold at prices ranging from $52.90 to $53.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F11The shares were sold at prices ranging from $54.15 to $55.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F12The shares are held by BioGrowth Partners, LP. The reporting person is the sole general partner of BioGrowth Partners, LP and has sole voting and dispositive power over the shares held by BioGrowth Partners, LP.
F13Fully vested.
F2The shares were sold at prices ranging from $53.73 to $54.71. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3The shares were sold at prices ranging from $54.765 to $55.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4The shares were sold at prices ranging from $53.90 to $54.77. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5The shares were sold at prices ranging from $55.26 to $55.31. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F6The shares were sold at prices ranging from $52.305 to $53.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F7The shares were sold at prices ranging from $53.31 to $54.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F8The shares were sold at prices ranging from $54.31 to $55.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F9The shares were sold at prices ranging from $55.31 to $55.77. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.